MM-151
MM-151 is a humanized IgG1 monoclonal antibody targeting EGFR. MM-151 binds multiple regions of the EGFR extracellular domain (ECD) and reduces its mutations in circulating cell-free tumor DNA with EGFR resistance. MM-151 significantly inhibits EGFR signaling and cell growth. MM-151 can be used for drug-resistant cancers research, such as colorectal, non-small cell lung and triple negative breast cancer[1].
Product Specifications
CAS Number
1399724-72-1
UNSPSC
12352203
Target
EGFR
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
References & Citations
[1]Arena S, et al. MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations. Sci Transl Med. 2016 Feb 3;8 (324) :324ra14. |[2]Kearns JD, et al. Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic. Mol Cancer Ther. 2015 Jul;14 (7) :1625-36.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
232863-01 100 mg
(4-Benzyl-morpholin-2-ylmethyl) ethylamine ≥96% (HPLC)
Sign In for Pricing
View Details 232863-02 250 mg
(4-Benzyl-morpholin-2-ylmethyl) ethylamine ≥96% (HPLC)
Sign In for Pricing
View Details 232863-03 1 g
(4-Benzyl-morpholin-2-ylmethyl) ethylamine ≥96% (HPLC)
Sign In for Pricing
View Details 